| Primary |
| Acute Coronary Syndrome |
22.4% |
| Percutaneous Coronary Intervention |
13.3% |
| Acute Myocardial Infarction |
12.2% |
| Coronary Arterial Stent Insertion |
9.2% |
| Thrombosis In Device |
7.1% |
| Thrombosis Prophylaxis |
5.1% |
| Antiplatelet Therapy |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Stent Placement |
4.1% |
| Chest Pain |
2.0% |
| Condition Aggravated |
2.0% |
| Coronary Angioplasty |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Myocardial Infarction |
2.0% |
| Stent Embolisation |
2.0% |
| Surgery |
2.0% |
| Anticoagulant Therapy |
1.0% |
| Cardiac Disorder |
1.0% |
| Coronary Artery Thrombosis |
1.0% |
| Dyspnoea |
1.0% |
|
| Thrombocytopenia |
28.6% |
| Drug Ineffective |
6.1% |
| Post Procedural Haemorrhage |
6.1% |
| Drug Interaction |
4.1% |
| Gastrointestinal Haemorrhage |
4.1% |
| Haematuria |
4.1% |
| Haemorrhage |
4.1% |
| Hypersensitivity |
4.1% |
| Hypotension |
4.1% |
| Platelet Count Decreased |
4.1% |
| Pulmonary Alveolar Haemorrhage |
4.1% |
| Pulmonary Haemorrhage |
4.1% |
| Retroperitoneal Haematoma |
4.1% |
| Thrombosis |
4.1% |
| Upper Gastrointestinal Haemorrhage |
4.1% |
| Abdominal Pain |
2.0% |
| Cardiogenic Shock |
2.0% |
| Epistaxis |
2.0% |
| Gastric Haemorrhage |
2.0% |
| Gastrointestinal Mucosal Disorder |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
38.5% |
| Acute Coronary Syndrome |
16.9% |
| Product Used For Unknown Indication |
16.2% |
| Acute Myocardial Infarction |
5.8% |
| Anticoagulant Therapy |
5.5% |
| Ischaemic Stroke |
3.8% |
| Percutaneous Coronary Intervention |
3.6% |
| Thrombosis Prophylaxis |
1.9% |
| Catheterisation Cardiac |
1.4% |
| Coronary Arterial Stent Insertion |
1.4% |
| Antiplatelet Therapy |
0.7% |
| Premedication |
0.7% |
| Arterial Occlusive Disease |
0.5% |
| Hypothyroidism |
0.5% |
| Ill-defined Disorder |
0.5% |
| Myocardial Infarction |
0.5% |
| Peripheral Arterial Occlusive Disease |
0.5% |
| Platelet Aggregation Inhibition |
0.5% |
| Angiogram |
0.3% |
| Atrial Fibrillation |
0.3% |
|
| Thrombocytopenia |
17.4% |
| Haemoglobin Decreased |
11.6% |
| Haemorrhage Intracranial |
7.2% |
| Hypotension |
5.8% |
| Neurological Decompensation |
5.8% |
| Thrombosis |
5.8% |
| Drug Ineffective |
4.3% |
| Gastrointestinal Haemorrhage |
4.3% |
| Thrombosis In Device |
4.3% |
| Ventricular Fibrillation |
4.3% |
| Compartment Syndrome |
2.9% |
| Death |
2.9% |
| Depressed Level Of Consciousness |
2.9% |
| Gastric Haemorrhage |
2.9% |
| Haemorrhagic Anaemia |
2.9% |
| Myocardial Infarction |
2.9% |
| Post Procedural Haemorrhage |
2.9% |
| Renal Failure |
2.9% |
| Renal Failure Acute |
2.9% |
| Respiratory Disorder |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.0% |
| Multiple Myeloma |
11.5% |
| Product Used For Unknown Indication |
9.8% |
| Acute Coronary Syndrome |
7.5% |
| Pain |
7.2% |
| Hypertension |
3.7% |
| Percutaneous Coronary Intervention |
3.2% |
| Anxiety |
2.6% |
| Coronary Artery Disease |
2.5% |
| Deep Vein Thrombosis |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hiccups |
2.3% |
| Metastases To Bone |
2.3% |
| Acute Myocardial Infarction |
2.0% |
| Anticoagulant Therapy |
1.8% |
| Catheterisation Cardiac |
1.7% |
| Coronary Artery Dissection |
1.5% |
| Insomnia |
1.5% |
| Stent Placement |
1.2% |
| Coronary Artery Bypass |
1.1% |
|
| Wound Drainage |
13.3% |
| Vascular Pseudoaneurysm |
11.7% |
| Cardiac Tamponade |
8.3% |
| Vomiting |
6.7% |
| Death |
5.0% |
| Hypotension |
5.0% |
| Systemic Inflammatory Response Syndrome |
5.0% |
| Thrombosis In Device |
5.0% |
| Arteriosclerosis |
3.3% |
| Coronary Artery Occlusion |
3.3% |
| Drug Ineffective |
3.3% |
| Haemoglobin Decreased |
3.3% |
| Infusion Related Reaction |
3.3% |
| Intra-uterine Death |
3.3% |
| Myocardial Infarction |
3.3% |
| Myocardial Rupture |
3.3% |
| Poor Quality Drug Administered |
3.3% |
| Pulmonary Embolism |
3.3% |
| Rash Maculo-papular |
3.3% |
| Renal Failure Acute |
3.3% |
|
| Interacting |
| Pneumonia Staphylococcal |
100.0% |
|
| Platelet Count Decreased |
100.0% |
|
